Sections

Home | Infections | Hepatitis

Hepatitis

Tricks of Ticking time bomb Hepatitis B Virus

Hepatitis B virus (HBV) causes hepatitis B, an infectious disease that afflicts 230 million people worldwide, thereof 440 000 in Germany. Persistence ...

Hepatitis C: once the viral infection has healed, high-risk portal vein hypertension also diminishes

This inflammatory viral infection of the liver causes inflexible scar tissue to form. This in turn impedes blood flow through the ...

New Test Allows for One-Step Diagnosis of HCV Infection

The current standard in diagnosing Hepatitis C virus (HCV) infection requires two sequential steps that make it suboptimal, costly, inconvenient, time consuming, and globally not widely available or affordable. ... Full story

Viral Hepatitis Can Be Eliminated If It Is a Top Priority

Scientists' interim report cites cost and logistics as barriers to ending “silent killer” in U.S. ... Full story

Hepatitis C clinic's expertise, dedication aids patients

by Joe Evans, Nebraska Medicine - Mark Mailliard, M.D., chief of the division of gastroenterology and hepatology at UNMC. ... Full story

Hepatitis C prevention and control efforts should focus on incarcerated individuals, according to new study

By Corinne Ton That - More than one in nine people with hepatitis C in Canada spend time in a correctional facility each year and researchers said this presents a unique opportunity to focus on hepatitis C prevention and control efforts in incarcerated populations. ... Full story

Hepatitis C screening of prison inmates would benefit wider community and be cost-effective

The benefits of screening prison inmates for infection with the hepatitis C virus (HCV) and treating those who test positive for the infection would extend far beyond the prison population, according to projections made by investigators from Massachusetts General Hospital (MGH),the University of Pittsburgh Graduate School of Public Health, Georgia Institute of Technology and Emory University. ... Full story

Enhanced treatment for hepatitis C could cut prevalence by 80%

By Ziba Kashef - Novel antiviral therapies for hepatitis C could reduce the prevalence of the blood-borne infection by more than 80%, according to an analysis by Yale researchers. The finding raises the possibility of greatly reducing, and even eliminating, hepatitis C in the United States if enhanced screening and treatment efforts target high-risk populations. ... Full story

Cell research shows pathway for suppressing hepatitis B virus

(Okayama ) Research led by Okayama University Graduate School of Medicine identifies the signalling pathway for hepatitis B virus recognition and suppression, suggesting a possible anti-viral strategy for the disease. ... Full story

Trinity Scientists Homing in on New Hepatitis C Vaccine

Trinity researchers have just commenced a major new study to evaluate a new vaccine for the prevention of Hepatitis C infection in HIV patients, who are at increased risk of contracting the common infection. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 107 | displaying: 1 - 10